Print
EmailMessage from the Vice Dean for Science Dafna Bar-Sagi, PhD
Dafna Bar-Sagi
Senior Vice President
Vice Dean for Science
Chief Scientific Officer
We have been busy these past six months, so some pleasant news may not have penetrated—news that is worth reiterating and reflects the dedication of faculty and staff to our research and education missions.
US News and World Report’s "Best Medical Schools: Research" list has NYU School of Medicine over the past six years moving up from 34th to 21st place, a 38% improvement. This is corroborated by our NIH funding rank, up from 35th to 24th (31% upswing), in the list of medical schools—all amidst diminishing NIH budgets and some of the worst financial times in the US since the Great Depression. Thus, in spite of the seemingly depthless uncertainty in Washington about federal budgets and the consequences for science, we have performed amazingly well.
At the Sackler Institute, out of 13,000 students nationally who applied for prestigious National Science Foundation Graduate Fellowships, two Sackler students won awards and another received honorable mention. Closer to home, for the 3rd year in a row, a Sackler Institute graduate student received NYU’s highest student honor, the Dean’s Outstanding Dissertation Award. Our students are enjoying the benefits of some top training programs. As of this month, we have accrued two ‘perfect 10’ scores from NIH for our graduate programs, last year for Immunology and Inflammation (Mike Dustin, PhD, PI) and this year for Microbiology (Ian Mohr, PhD, PI). The national committees that have reviewed these grants are impressed with the quality of the programs, the diverse faculty, the track record of the training programs in placing their graduates and postdocs, and our impressive record of recruiting and retaining underrepresented minorities into the program.
A number of our faculty have also recently attracted national attention. In February, Jan Vilcek, MD, PhD, received the nation’s highest honor for technology, the National Medal for Technology and Innovation, for co-inventing Remicade, the anti-inflammatory biologic that has already treated more than 2 million patients around the world. In late April came word of the induction of Marty Blaser, MD, into the American Academy of Arts and Sciences and the election of Ruth Nussenzweig, PhD, and Joseph LeDoux, PhD, into the National Academy of Sciences. Finally, hot off the presses, Evgeny Nudler, PhD, was just named NYULMC’s newest Howard Hughes Medical Institute Investigator.
These rankings, awards and recognitions illustrate yet again how we continue to defy the odds and define our own future.
Dafna Bar-Sagi
Senior Vice President
Vice Dean for Science
Chief Scientific Officer
We have been busy these past six months, so some pleasant news may not have penetrated—news that is worth reiterating and reflects the dedication of faculty and staff to our research and education missions.
US News and World Report’s "Best Medical Schools: Research" list has NYU School of Medicine over the past six years moving up from 34th to 21st place, a 38% improvement. This is corroborated by our NIH funding rank, up from 35th to 24th (31% upswing), in the list of medical schools—all amidst diminishing NIH budgets and some of the worst financial times in the US since the Great Depression. Thus, in spite of the seemingly depthless uncertainty in Washington about federal budgets and the consequences for science, we have performed amazingly well.
At the Sackler Institute, out of 13,000 students nationally who applied for prestigious National Science Foundation Graduate Fellowships, two Sackler students won awards and another received honorable mention. Closer to home, for the 3rd year in a row, a Sackler Institute graduate student received NYU’s highest student honor, the Dean’s Outstanding Dissertation Award. Our students are enjoying the benefits of some top training programs. As of this month, we have accrued two ‘perfect 10’ scores from NIH for our graduate programs, last year for Immunology and Inflammation (Mike Dustin, PhD, PI) and this year for Microbiology (Ian Mohr, PhD, PI). The national committees that have reviewed these grants are impressed with the quality of the programs, the diverse faculty, the track record of the training programs in placing their graduates and postdocs, and our impressive record of recruiting and retaining underrepresented minorities into the program.
A number of our faculty have also recently attracted national attention. In February, Jan Vilcek, MD, PhD, received the nation’s highest honor for technology, the National Medal for Technology and Innovation, for co-inventing Remicade, the anti-inflammatory biologic that has already treated more than 2 million patients around the world. In late April came word of the induction of Marty Blaser, MD, into the American Academy of Arts and Sciences and the election of Ruth Nussenzweig, PhD, and Joseph LeDoux, PhD, into the National Academy of Sciences. Finally, hot off the presses, Evgeny Nudler, PhD, was just named NYULMC’s newest Howard Hughes Medical Institute Investigator.
These rankings, awards and recognitions illustrate yet again how we continue to defy the odds and define our own future.
